The residual ovary syndrome: A 20-year experience

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 68, Issue 1-2, 1996, Pages 159-164

  Dekel, Arie ^a,b   Efrat, Zeev ^a,b   Orvieto, Raoul ^a,b   Levy, Tally ^a,b   Dicker, Dov ^a,b   Gal, Rivka ^a,b   Ben Rafael, Zion ^a,b  

^a HASHARON HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Malignancy; Oophorectomy; Residual ovary syndrome

Indexed keywords

AGE; ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OVARIECTOMY; OVARY DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030249035     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)00250-3     Document Type: Article

References (39)

1. [1] Dexeus S, Munoz A, Tusquets JM. Preservation of the ovaries: a controversial subject. Eur J Obstet Gynecol Reprod Biol 1988; 28: 146-154.
2. [2] Grogan RH. Residual ovary. Obstet Gynecol 1958; 12: 329-332.
3. [3] Terz JJ, Barber HRK, Brunschwig A. Incidence of carcinoma in the retained ovary. Am J Surg 1967; 113: 511-515.
4. [4] Wright RC. Hysterectomy: past, present, and future. Obstet Gynecol 1969; 33: 560-563.
5. [5] Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gyncecol 1990; 163: 1438-444.
6. [6] Speroff T, Dawson NV, Speroff C, Haber RJ. A risk-benefit analysis of elective bilateral/oophorectomy: effect of changes in compliance with estrogen therapy on outcome. Am J Obstet Gynecol 1991; 164: 165-174.
7. [7] Hahn RG. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet. Gynecol 1989; 161: 1854-1858.
8. [8] Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994; 83: 549-555.
9. [9] Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-1984. Washington: National Center for Health Statistics. US Government Printing Office, 1987, DHHS publication No. (PHS) 87-1753. (vital and health statistics, series 13, No. 92).
10. [10] Grogan RH, Duncan CJ. Ovarian salvage in routine abdominal hysterectomy. Am J Obstet Gynecol 1955; 70: 1277-283.
11. [11] Christ JE, Lotze EC. The residual ovary syndrome. Obstet Gynecol 1975; 46: 551-556.
12. [12] Bukovsky I, Liftshitz Y, Langer R, Weinraub Z, Sadovsky G, Caspi E. Ovarian residual syndrome. Surg Gynecol Obstet 1988; 167: 132-134.
13. [13] Ranney B, Abu-Ghazaleh S. The future function and fortune of ovarian tissue which is retained in vivo during hysterectomy. Am J Obstet Gynecol 1977; 128: 626-632.
14. [14] De Neef JC, Hollenbeck Z Jr. The fate of ovaries preserved at the time of hysterectomy. Am J Obstet Gynecol 1966; 96: 1088-1097.
15. [15] Grogan RH. Reappraisal of residual ovaries. Am J Obstet Gynecol 1967; 97: 124-129.
16. [16] McGowen L. Ovarian cancer after hysterectomy. Obstet Gynecol 1987; 69: 386-388.
17. [17] Gibbs EK. Suggested prophylaxis for ovarian cancer. Am J Obstet Gynecol 1971; 111: 756-765.
18. [18] Bloom ML. Certain observations based on a study of 141 cases of primary adenocarcinoma of the ovaries (1950-1959). S Afr Med J 1962; 36: 714-717.
19. [19] Counsellor VS, Hunt W, Haigler H. Carcinoma of the ovary following hysterectomy. Am J Obstet Gynecol 1955; 69: 538-546.
20. [20] Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy. A 14-year experience at the University of Miami. Obstet Gynecol 1991; 78: 681-684.
21. [21] Parazzini F, Negri E, LaVeccia C, Luchini L, Mezzopane R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet Gynecol 1993; 81: 363-366.
22. [22] Reycraft JL. (Discussion of: Counsellor VS, Hunt W, Haigler H. Carcinoma of the ovary following hysterectomy). Am J Obstet Gynecol 1955; 69: 543-544.
23. [23] Naylor AC. Hysterectomy-analysis of 2901 personally performed procedures. S Afr Med J 1984; 65: 242-245.
24. [24] Cutler SJ, Young JL, eds. Third national cancer survey: Incidence data. National Cancer Institute Monograph 41, DHEW publication (NIH) 75-787. Washington DC: United States Government Printing Office, 1975.
25. [25] Randall CL, Gerhart PR. The probability of occurrence of the more common types of gynecological malignancies. Am J Obstet Gynecol 1954; 68: 1378-1385.
26. [26] Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D, The Collaborative Ovarian Cancer Group. Rates and risks of ovarian cancer in subgroups of white women in the United States. Obstet Gynecol 1994; 87: 760-764.
27. [27] Wynder EL, Dodo H, Barber HRK. Epidemiology of cancer of the ovary. Cancer 1969; 23: 352-370.
28. [28] Annegers JF, Storm H, Decker DG, Dockerty MB, O'Fallon WM. Ovarian cancer incidence and case-control study. Cancer 1979; 43: 723-729.
29. [29] Cramer DW, Hutchinson GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71: 711-716.
30. [30] McGowen L, Parent L, Lednar W, Norris HJ. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979; 7: 325-344.
31. [31] Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991; 134: 362-369.
32. [32] Weiss NS, Harlow BL. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer? Am J Epidemiol 1986; 124: 856-858.
33. [33] Cramer DW, Welch WR, Schully RE, Wojciechowski CA. Ovarian cancer and talk: a case-control study. Cancer 1982; 50: 372-376.
34. [34] Graham J, Graham R. Ovarian cancer and asbestos. Environ Res 1967; 1: 115-128.
35. [35] Cattanach JF, Milne BJ. Post-tubal sterilization problems correlated with ovarian steroidogenesis. Contraception 1988; 38: 541-550.
36. [36] Siddle N, Sarrel P, Whithead M. The effect of hysterectomy on the age at ovarian failure; identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987; 47: 94-100.
37. [37] Jansson PO, Jansson I. The acute effect of hysterectomy on ovarian blood flow. Am J Obstet Gynecol 1977; 127: 349-352.
38. [38] Backstrom CT, Boyle H. Persistence of premenstrual symptoms in hysterectomized women. Br J Obstet Gynecol 1981; 88: 530-535.
39. [39] Borell U, Fernstrom J. The adnexal branches of the uterine artery. Acta Radiol 1953; 40: 561-564.